Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have searched for 20ml semaglutide, you are most likely trying to make sense of the volume printed on a Wegovy pen or a prescription label. The short answer: each pre-filled Wegovy pen contains 3ml of solution, and the figure you have seen elsewhere probably refers to a multi-dose vial format that does not exist as a licensed UK weight-loss product. Semaglutide for weight management in the UK is prescribed as a single-use, pre-filled injection pen, dispensed through a pharmacy after a clinical assessment by a prescriber. Understanding the difference between volume and dose matters, because searching for a 20ml vial of semaglutide can lead people towards unlicensed, unverified sources that carry real safety risks — something the MHRA's Yellow Card scheme continues to receive reports about.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is some version of: "I've seen a 20ml or 10ml vial listed online) is that the same thing?" It is not. Wegovy, the semaglutide product licensed for weight management in the UK, comes as a pre-filled injection pen containing 3ml of solution. Each pen delivers four weekly doses at the prescribed strength, you do not draw up fluid yourself, and there is no vial to decant from. The dose is fixed by the pen's setting and confirmed by your prescriber.
The milligram figure (0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg, or the newer 7.2mg) is what drives the clinical effect. The 3ml of carrier solution is simply the medium that delivers it. So when a search returns results for a 10ml semaglutide product, that volume description does not match any pen on the UK market, and the same is true if you come across a 20ml semaglutide listing, which equally has no equivalent among authorised UK pens. You can read more about how the standard Wegovy pen works on our Wegovy overview page.
This distinction is not pedantic. Unlicensed compound semaglutide in vials (common in some other countries) has been linked to dosing errors and contamination. The NHS medicines page for semaglutide makes clear that the only route to lawfully obtaining it in the UK for weight management is a prescription for a named, authorised product.
Compounded or "grey market" semaglutide vials became widely discussed during the global shortage of 2022 to 2024, when demand for GLP-1 medicines outstripped supply. In the United States, compounding pharmacies were temporarily permitted to fill the gap with multi-dose vials (including higher-volume presentations) under FDA shortage provisions. That permission has since been curtailed, but the search terms stuck.
In the UK, no such compounding exemption applied or applies. The MHRA has not authorised any multi-dose vial of semaglutide for weight management, and buying from a source that sells it in that format, without a valid UK prescription, puts you at the same risk as buying any counterfeit injectable: unknown concentration, unverified sterility, incorrect dosing. None of those risks is theoretical. The MHRA has already acted against multiple suppliers of unlicensed injectable weight-loss products.
If you are considering semaglutide for weight loss, the starting point is a consultation with a prescriber, not a search for a specific volume. Our weight-loss treatment overview covers how the licensed options compare and what the clinical pathway looks like.
Wegovy treatment follows a stepped titration) not because more is always better immediately, but because your digestive system adapts better when the dose rises gradually. The schedule runs from 0.25mg (for the first month), through 0.5mg, 1.0mg and 1.7mg, up to the 2.4mg maintenance dose, each step taking roughly four weeks. The MHRA approved a higher 7.2mg maintenance option in April 2026 for patients who need it, available as a dedicated single-dose pen.
None of this schedule involves measuring fluid. You click the pen, inject at the prescribed moment each week, and the device handles the rest. Your prescriber reviews your progress before any dose change, at nume, that means a clinical re-review before every repeat order, carried out by a GPhC-registered Independent Prescriber, not an automated system.
What the dose schedule does mean practically: your first pen is a lower-dose pen, not the maintenance dose. Searching for a high-volume or high-dose product to start on skips the adjustment phase that makes treatment tolerable. It is also one of the red flags that separates legitimate clinical supply from unlicensed sellers.
The safest, legally correct route to semaglutide for weight management in the UK runs like this: a consultation (including identity and weight verification), assessment by a prescriber who checks your medical history, a prescription if you are clinically suitable, and dispensing by a pharmacy you can verify on the GPhC pharmacy register. That register is publicly searchable, every legitimate online pharmacy has a premises registration number listed there.
For context on what private treatment costs, our Wegovy pricing page sets out what is included in a single transparent price and explains why the cheapest listing is rarely the right measure for a prescription medicine. If you have questions about drug interactions while on semaglutide, our page on taking naproxen with semaglutide is one example of the clinical detail our prescribers cover.
If you are ready to find out whether semaglutide is right for you, the sensible next step is a proper consultation rather than a product search. Speak to our prescribers through a free assessment, and a clinician will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.